1,721,050 research outputs found
MSJ846100_supplemental_table_2 – Supplemental material for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis
No full textSupplemental material, MSJ846100_supplemental_table_2 for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis by Tine Iskov Kopp, Morten Blinkenberg, Thor Ameri Chalmer, Thor Petersen, Mads Henrik Ravnborg, Per Soelberg Sørensen and Melinda Magyari in Multiple Sclerosis Journal</p
MSJ846100_supplemental_table_1 – Supplemental material for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis
No full textSupplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis by Tine Iskov Kopp, Morten Blinkenberg, Thor Ameri Chalmer, Thor Petersen, Mads Henrik Ravnborg, Per Soelberg Sørensen and Melinda Magyari in Multiple Sclerosis Journal</p
MSJ846100_supplemental_table_4 – Supplemental material for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis
No full textSupplemental material, MSJ846100_supplemental_table_4 for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis by Tine Iskov Kopp, Morten Blinkenberg, Thor Ameri Chalmer, Thor Petersen, Mads Henrik Ravnborg, Per Soelberg Sørensen and Melinda Magyari in Multiple Sclerosis Journal</p
MSJ846100_supplemental_table_3 – Supplemental material for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis
No full textSupplemental material, MSJ846100_supplemental_table_3 for Predictors of treatment outcome in patients with paediatric onset multiple sclerosis by Tine Iskov Kopp, Morten Blinkenberg, Thor Ameri Chalmer, Thor Petersen, Mads Henrik Ravnborg, Per Soelberg Sørensen and Melinda Magyari in Multiple Sclerosis Journal</p
sj-DOC-1-tan-10.1177_17562864211058298 – Supplemental material for Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
No full textSupplemental material, sj-DOC-1-tan-10.1177_17562864211058298 for Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice by Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh and Bassem Yamout in Therapeutic Advances in Neurological Disorders</p
Interferon-beta-1a: therapeutic effects, tolerability, current and future status in multiple sclerosis
No full text
- …
